![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 27, 20274-20279, July 7, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Unidad de Farmacología, Facultad de Medicina,
Universidad de La Laguna, 38071 La Laguna, Tenerife, Spain
Received for publication, February 4, 2000, and in revised form, March 8, 2000
The effects of nitric oxide (NO) on the late
phase of exocytosis have been studied, by amperometry, on
Ba2+-stimulated chromaffin cells. Acute incubation
with NO or NO donors (sodium nitroprusside, spermine-NO,
S-nitrosoglutathione) produced a drastic slowdown of the
granule emptying. Conversely, cell treatment with
N NO is a short-lived, highly reactive radical involved in several
physiological functions such as vasodilatation, macrophage mobility,
cytotoxicity, or gene transcription (see Ref. 1 for a review). In
addition, NO is a modulator of neurotransmitter-mediated responses in
the central nervous system (2).
In the adrenal gland, NO could be secreted from the chromaffin cell
itself (3), or paracrine, being secreted from contiguous endothelium
(4). In addition, NO could also be released by afferent nerves (5, 6).
To date, many in vitro studies have been carried out to
elucidate the role of NO/cGMP on the secretory processes of chromaffin
cells. Results are still controversial; O'Sullivan and Burgoyne (7)
reported a potentiation of
CA1 release induced by
various NO-releasing agents, whereas others have found a
dose-dependent inhibition of secretion (8, 9), or no
changes at all (10, 11). NO is also reported to increase basal
secretion (3, 9). NO induces CA synthesis through tyrosine hydroxylase
activation (11). The present view is that the main role of NO is the
control of adrenal blood flow, whereas its modulation on the bulk of CA
release seems to be small (12).
Catecholamines and other soluble components are stored within
chromaffin granules at very high concentrations: 0.5-1
M (13-16), thus creating a high intragranular osmotic
pressure. Complexation of intragranular substances will reduce the
osmotic forces, thereby preventing granule lysis (15-18). No
mechanisms are known at present that regulate this intragranular matrix complex.
Amperometric techniques allow the direct observation of time-course
kinetics of single secretory events and have been successfully used to
study the late phase of exocytosis (19-22).
Here, we show conclusively that NO, acting on the guanylate cyclase
cascade, produces dramatic changes on quantal release of CA by single
chromaffin cells, probably acting on the intragranular matrix. To our
knowledge, this is the first experimental report suggesting that the
kinetic of vesicular release can be modulated by drugs or second
messengers. In addition, we have found evidence indicating that the
interaction of intragranular components can be modulated under
physiological conditions. If this effect of NO were extended to dense
core vesicles of sympathetic neurons, it would result in significant
changes on synaptic efficacy, even releasing the same amount of
noradrenaline quanta.
Materials--
Noradrenaline, SNP, IBMX, zaprinast, methylene
blue, 8-Br-cGMP, cultured media, sera, and collagenase type IA were
purchased from Sigma-Aldrich (Madrid, Spain). Fura-2/AM, Pluronic acid, and S-nitrosoglutathione were obtained from Molecular Probes
(Eugene, OR). Spermine-NO, L-NAME, and C-PTIO were
purchased from RBI (Natick, MA). NO gas (N30) was purchased from Air
Liquide (Tenerife, Spain). Urografin® was obtained from
Schering España (Madrid, Spain). Culture plates were from
Corning (Cambridge, MA). All salts used for buffer preparation were
reagent grade.
Culture Chromaffin Cells--
Bovine adrenal chromaffin cells,
enriched in adrenaline, were prepared as described elsewhere (23).
Cells were planted on 12-mm diameter glass coverslips at an approximate
density of 5 × 105 cells/coverslip. Cells were
maintained at 37 °C in a 5% CO2 environment and used at
room temperature between 1 and 4 days of culture.
Amperometric Detection of Exocytosis--
Carbon fiber
microelectrodes were prepared as described (24). Carbon fibers (5 µm
radius; Thornel P-55, Amoco Corp., Greenville, SC) were the kind gift
of Prof. R. M. Wightman (University of North Carolina at Chapel
Hill, NC). Electrochemical recordings were performed using an Axopatch
200B (Axon Instruments, Foster City, CA). A fixed potential of +650 mV
was maintained between the carbon fiber electrode versus an
Ag/AgCl pellet reference electrode. Electrodes were backfilled with 3 M KCl to connect to the headstage. Electrodes were tested
with a flow-injection system with noradrenaline standard solutions
using an EI-400 potentiostat (Ensman Inst. Bloomington, IN) (24).
Glass coverslips with adhering adrenal cells were washed in Krebs-HEPES
buffer solution containing (in mM): NaCl (140), KCl (5),
MgCl2 (1.2), CaCl2 (2), glucose (11), and HEPES
(10), brought to pH 7.35 with NaOH. Cells were placed in a perfusion chamber positioned on the stage of an inverted microscope (Leica DM-IRB, Wetzlar, Germany). Amperometric measurements were performed with the carbon fiber microelectrode gently touching the cell membrane.
Cell release was stimulated by 5-s pressure ejection of 5 mM Ba2+ from a micropipette placed 40 µm away
from the cell. Ba2+ was used as a secretagogue because it
does not require receptor activation or membrane depolarization and
because it produces a low frequency of secretory event, so that during
spike analysis the initial and final points of each wave can be easily distinguished.
Experiments using hypertonic solutions were performed as described
previously (22). Briefly, cells were incubated in hypertonic Krebs (750 mosM, obtained by adding NaCl) solution for 5 min, in the
presence or in the absence of 10 µM SNP. Under these
hypertonic conditions, secretion was elicited by pulse injection of
isotonic Krebs solution.
NO Solutions--
In order to reduce NO degradation, free
O2 was reduced from the stock solution. Krebs solution was
bubbled with pure N2 into a sealed bottle for about 60 min.
Five milliliters of the above solution were transferred into 7-ml
sealed vials and bubbled again for another 10 min, keeping a pure
N2 atmosphere in the empty space. This degassing procedure
reduced the pO2 to 15-20 mmHg (ABL-2, Radiometer,
Copenhagen, Denmark), equivalent to 20-40 µM free
O2.
In a fume hood, NO gas was on-line bubbled through a sealed bottle
containing 5 N NaOH, to get rid of acid-generated material and then to an empty 7-ml vial for 1 min at 0.5 bar, maintaining the
flow for 5 min. Two milliliters of the deoxygenated solution were
injected into the vial containing pure NO using a gas-tight syringe
through a rubber stopper. The vial was kept at 4 °C and used within
2 h. NO concentration in the solution, measured by Griess method,
was 2.8 mM.
Data Analysis--
Amperometric signals were low-pass filtered
at 1 KHz and sampled at 4 KHz and collected using a locally written
software (Labview for Macintosh, National Instruments, Austin, TX).
Data analysis was carried out using locally written macros for IGOR
(Wavemetrics, Lake Oswego, OR). These macros allow the automatic
digital filtering, secretory spike identification, and build histograms
for spike classification. All the above macros are free shareware.
Fig. 1 describes the parameters measured
from each secretory spike. Once the beginning and the end points were
found, the computer obtained the maximum amplitude of the oxidation
current (Imax), which was expressed in pA. The
ascending slope (m) was determined from the linear part of
the trace located between 25% and 75% of the
Imax; hence, this parameter is not affected by the presence of the pre-spike phenomenon (foot), m being
expressed in nA/s. The time to peak (tP) was
determined between the point at which the back-extrapolation of the
slope line crossed the base line and the point of
Imax. This parameter partially shows the slow
dissociation of adrenaline from intragranular proteic matrix. Total
granule release (Q) was obtained by integration of the
curve, which indicates the amount of oxidizing substances released and
is expressed in pC. Q was normalized as the cubic root
(Q1/3) and two spike fade constants (
Because of day-to-day variations in electrode sensitivity and cell
responsiveness, significant differences were currently observed between
untreated cells, used as controls, from different days. For this
reason, effects of drugs on secretory spikes were compared with control
experiments carried out under the same conditions. Statistical analysis
was carried out by the non-parametric Mann-Whitney U test.
Measurement of Cytosolic
[Ba2+]c--
Glass coverslips with adhering
adrenal cells were washed twice in Krebs buffer solution and incubated
with 2 µM fura-2/AM (stock solution dissolved in 20%
Pluronic F-127 in Me2SO) and 0.1% fetal calf serum for 45 min. Cells were then washed twice to remove extracellular dye and
placed in the perfusion chamber, as described above. Intracellular
Ba2+ was measured using a computer-operated monochromator
(TILL Photonics, Munich, Germany) controlled by Labview software.
Fluorescence signals were low-pass filtered at 510 nm and detected by a
photomultiplier mounted to a viewfinder (TILL Photonics) that defined
the area of interest over which the fluorescence intensity was integrated.
Data of [Ba2+]c time courses were collected
at 10 Hz and expressed as fluorescence ratios
(F360) and (F380).
NO Affected the Time Course of Secretory Spikes--
The direct
application of NO produced drastic effects on the time course of
secretory spikes, which are summarized on Table I and II. These effects were reproduced
with all of the NO donors tested (Table
II). Spermine-NO was particularly potent
promoting a fall in granules emptying kinetics. Incubation with
S-nitrosoglutathione and direct NO application produced
similar concentrationdependent changes, which relate closely to
their described abilities for producing free NO (25). Spike decay was
also affected;
Fig. 2 shows histograms from secretory
spikes obtained in the absence or in the presence of 10 µM of the NO donor SNP incubated for 10-20 min. SNP
caused a dramatic reduction in the spike Imax, averaging a fall to a 36% of control that was accompanied by a t1/2 average increase of 161% (Table II).
Virtually, no spikes over 60 pA were found upon SNP treatment.
Conversely, the number of events with a t1/2 of
over 40 ms was greatly increased. The releasing speed decayed as the
ascending slopes of spikes were drastically reduced. The histogram in
Fig. 2 shows that the number of secretory events with a
tP over 10 ms in duration was largely increased.
NO effects were even more pronounced with 100 µM SNP, but
a dramatic reduction in the number of spikes prevented us from using
these data. Total granule release remained unaltered at low
concentration of the drug, whereas a reduction was observed when SNP
was raised to 10 µM.
In order to rule out SNP effects caused by NO metabolites accumulated
along drug incubation, 10 µM SNP was also applied for 10 s in the vicinity of a cell. The effects of this brief
application, although less pronounced, were qualitatively similar
(Table II); Imax dropped from 45 to 34 pA, and
t1/2 rose 36%.
Fig. 3 describes how NO affected the time
course of spikes. Incubation with 100 µM spermine-NO for 10 min produced a drastic change in
spike shape, which included a reduction in the
Imax and in the m (ascending slope),
accompanied with an increase in the tP,
Due to the large differences within control data from one day to
another, each treatment was compared with its own untreated control
cells, from the culture of the same day using the same electrode. Table
II shows data normalized with their own control. Although the effects
of NO on total CA released by Ba2+ were not analyzed in
detail, a discrete reduction in spike firing, of about 15%, was
observed. In addition, the average spike charge observed was reduced by
20-40%.
cGMP Mimicked the Effects of NO--
The guanylate cyclase PKG is
known to be the main cellular transduction system for NO. In order to
test if cGMP could mimic the NO effects, cells were treated with 10 µM cGMP-permeable analog 8-Br-cGMP. Results are
summarized on Table II. Incubation for 20-30 min caused changes of
spike shape qualitatively similar to those found with NO and NO donors.
The secretory speed was profoundly slowed, and spikes were
indistinguishable from NO-treated cells. Similarly,
Endogenous cellular levels of cGMP can also be increased by inhibiting
its degradation. Table II shows the effects of 20 min of incubation
with two phosphodiesterase inhibitors, IBMX and the more specific
inhibition of cGMP-phosphodiesterase, zaprinast. When applied alone,
both substances produced net changes on spike shape similar to those
observed with NO donors. In the presence of 10 µM SNP,
slight additive effects were observed, suggesting that both agents act
through the same mechanism. Zaprinast increased NOS Inhibition Accelerated the Last Stage of Exocytosis--
Cells
were treated with L-NAME at 37 °C for 30 min and
exocytotic spikes recorded in the presence of the drug. Low
L-NAME concentrations (10 µM) promoted
significant changes on the spike t1/2,
m, and tP values (Table II). Although
data obtained with 100 µM L-NAME were
qualitatively similar, they should be interpreted with caution because
of the total granule release reduction observed (44%). The effects of
L-NAME persisted during incubation but rapidly disappeared
upon drug removal, indicating a reversible NOS inhibition. High
L-NAME concentrations (1 mM) resulted in a
drastic reduction of the number of secretory spikes, probably due to a
nonspecific or toxic effect (data not shown).
NO Reduction Promoted an Increase in the Number of Sharper
Spikes--
The presence of NOS within chromaffin cells suggested the
existence of a NO basal tone which probably modulates continuously the
kinetics of the exocytosis. This basal tone was revealed by NO
sequestration using NO scavengers. Table II shows the effects of cell
incubation with methylene blue and C-PTIO on Ba2+-evoked
secretory spikes. Neither methylene blue nor C-PTIO caused CA release.
However, both agents induced a concentration-dependent reduction of the t1/2, which was accompanied
with an increase in m and a shortening of
tP. C-PTIO was more potent than methylene blue,
probably because of its specificity and ability to serve as NO
scavenger; the Imax was significantly increased
to 223% after only 4-5 min of incubation, revealing the presence of a basal NO activity within cultured cells. An unexpected effect observed
with NO scavengers was the changes found on spike charge. Table II
shows that C-PTIO increased Q, whereas methylene blue induced a reduction. However, in all cases, an increase in the Imax together with a reduction in
t1/2 and NO Donors Did Not Reduce the
[Ba2+]c--
One possible target site of NO
could be the interference with Ba2+ movements. A series of
experiments was done measuring [Ba2+]c in the
absence and in the presence of 10 µM SNP. Fig. 5 shows representative traces of
F360/F380 ratios obtained
with cells loaded with fura-2. Cells treated with SNP showed no changes
on the ascending part of the traces. However, a significant increase on
[Ba2+]c of 18 ± 2% was observed on the
plateau of [Ba2+]c traces (6 cells of each
group). In any case, the increased [Ba2+]c
levels were maintained in both groups of cells for 6-8 min after
the stimulus, the time usually taken for amperometric recording.
The Intragranular Matrix as the Probable Target of NO/Guanylate
Cyclase--
A series of experiments was carried out in order to
elucidate the cellular target site for NO. Foot (pre-spike feature)
duration indicates the elapsed time for formation of the fusion pore.
If a given substance modifies the fusion pore machinery, the duration of the foot might be altered. However, no differences on foot duration
were found between foot produced in control conditions and cells
incubated with 10 µM SNP: 17.4 ± 1.1 ms
(n = 99) versus 15.5 ± 1.2 ms
(n = 84), or 8-Br-cGMP: 14.8 ± 0.8 ms
(n = 87) versus 15.6 ± 1.3 ms
(n = 64). In amperometric recordings, only the 35% of
spikes exhibited foot (13, 19). In this study, measurements were only
performed on spikes where the beginning and finishing points of foot
were clearly distinguishable.
We have shown that cell stimulation under conditions of high tonicity
(i.e. >700 mosM), promoted the partial
exocytosis of chromaffin granules (22). Ba2+ application
caused an increase in the [Ba2+]c, which was
not accompanied by secretory spikes. However, exocytotic pore formation
had already occurred, as demonstrated by the fact that brief pressure
injection of isotonic saline caused many exocytotic events, which
lasted throughout the time of application. These secretory spikes had
lost 50% of their content, and they did not possess foot because they
came from pre-fusioned granules that could only swell in response to
isotonic media (Fig. 1
After Ba2+ stimulation under
hypertonic conditions, granules were already opened; changes produced
in spike shape must not be caused by an effect on the fusion pore but
on another target, probably on the affinity of CA for the intragranular
matrix. Data obtained from Fig. 6 (table inset)
show significant changes on spike shape obtained from pre-fusioned
granules, which mimicked those produced under normal conditions.
Moreover, pre-fusioned granules progressively lost CA, indicated by the
gradual fall in Q values along the time from
Ba2+ stimulation. NO partially prevented this loss. As
shown in Fig. 6, there were statistical differences between
Q values obtained from control and SNP groups,
indicating that NO increased the affinity of CA for its intragranular
matrix.
The results of this study demonstrate that NO, even at low
concentrations, produces profound effects on the kinetics of secretory spikes (Figs. 2 and 3). We also show that exocytosis is modulated by a
basal NO tone present within the cultured cells. Our data suggest that
most of the NO action is carried out through the guanylate cyclase PKG
pathway, as incubation with cGMP analog 8-Br-cGMP and phosphodiesterase
inhibitors mimicked NO effects.
Previous studies have reported changes on spike shape by altering
temperature (21), ionic composition (26-28), or osmotic strength (22)
of the extracellular media. Also, selective amino acid deletions on the
granule fusion complex protein, SNAP-25, caused changes on the quantal
release kinetics (29). However, these maneuvers are unlikely to occur
under physiological conditions.
A possible target site for NO would be the interaction with
Ca2+ homeostasis. Calcium participates in the fusion pore
dynamics (28) and in the regulation of the "kiss and run"
phenomenon (27). NO has been implicated in the modulation of
Ca2+ channels (30), as well as in the control of membrane
potential, through the activation of Ca2+-activated
K+ channels (31). Brief Ba2+ application, in
the absence of depolarizing stimuli, resulted in a slow and
long-lasting [Ba2+]c time course due to its
poor efflux from the cell (22, 32). Fig. 5 shows that SNP did not
reduced the [Ba2+]c responses but produced a
slight increase. These results do not support the assumption that NO
effects on exocytosis were caused by a reduction of
[Ba2+]c.
The time course of exocytosis could have been altered, at least,
through three mechanisms: changing the fusion pore expansion (27, 28,
33), altering the Cl Data presented here cannot conclude whether the target of NO/cGMP is
the fusion pore expansion, the Cl The possible role of cGMP kinase on the intragranular matrix is
difficult to explain since no cellular transduction routes have been
described so far to explain how a second messenger could modify the
kinetics of CA-CGA association. The only granule membrane protein,
described so far, capable of interacting with CGA is the
IP3 receptor (38, 39). However, although it is known that PKG can phosphorylate IP3 receptors (40), the real
existence of an IP3 receptor on granule surface has been
questioned (41).
It is possible that NO can interact with the movements of
Cl Fusion pore complex proteins posses several sites suitable for
phosphorylation by PKG and other kinases (37). A delay in the fusion
pore dilatation could produce a decrease in the speed of adrenaline. In
addition, Criado et al. (29) reported changes in the spike
kinetics parameters (t1/2, m,
tP) of exocytosis in chromaffin cells with
altered SNAP-25, one of the fusion pore complex proteins, although the
changes caused by NO on spike shape were qualitatively different from
those obtained in that study.
An effect of NO difficult to explain, however, is the change observed
in Q. Assuming that this parameter reflects the total amount
of adrenaline present within a granule, it is likely that this amount
should be kept constant regardless of the kinetics of release. It is
possible that NO can cause a true reduction in the quantal size of
released CA. However, the more likely explanation may be the
underestimation of spike charge resulting from the very slow release of
CA upon granule fusion (22). The flattened end of the wider spikes
implies very small concentrations of oxidative substances, which fall
under electrode detection threshold, and as a result they are missed
within base-line noise. Because the NO effect is observed a few seconds
after its application (Fig. 4), it cannot be caused by an inhibition of
CA synthesis (12) or by an inhibition of the monoamine carrier at the
granule membrane.
Considering that dense core vesicles and chromaffin granules are
similar organelles, NO could also modulate the speed of exocytosis in
sympathetic nerve terminals. This will result in a decrease in their
synaptic performance. In our study conditions, electrodes were touching
the cell membrane; the distance between the electrode and the cell
surface should be as short as an intervening water layer ( In conclusion, our experiments suggest that NO, acting through the
activation of the guanylate cyclase route, modifies the exocytotic
kinetics of chromaffin granules. The cellular target for cGMP could be
either the fusion pore dynamic or by altering the affinity of
intragranular matrix for CA. To our knowledge, this is the first report
indicating that, at its final stage, quantal secretion of a
neurotransmitter could be physiologically modulated.
We acknowledge the help of J. A. Navarro
in preparing NO solutions. We greatly appreciate discussion with
Drs. R. M. Wightman, E. W. Westhead, M. Feria, and A. G. García.
*
This work was supported in part by Grant DGCYT PB97-1483
from the Ministerio de Educación y Cultura (Spain).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 34-922-319346;
Fax: 34-922-655995; E-mail: rborges@ull.es.
Published, JBC Papers in Press, March 28, 2000, DOI 10.1074/jbc.M000930200
The abbreviations used are:
CA, catecholamine;
[Ba2+]c, cytosolic barium concentration;
8-Br-cGMP, 8-bromo-cGMP;
[Ca2+]c, cytosolic
calcium concentration;
C-PTIO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
potassium;
CGA, chromogranin A;
IBMX, 3-isobutyl-1-methylxanthine;
L-NAME, N
Nitric Oxide Modulates a Late Step of Exocytosis*,
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-nitro-L-arginine methyl ester
(a NO synthase inhibitor) or with NO scavengers (methylene blue,
2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide potassium) accelerated the extrusion of catecholamines from
chromaffin granules, suggesting the presence of a NO modulatory tone.
The incubation with phosphodiesterase inhibitors
(3-isobutyl-1-methylxanthine or zaprinast) or with the cell-permeant
cGMP analog 8-bromo-cGMP, mimicked the effects of NO, suggesting the
involvement of the guanylate cyclase cascade. NO effects were not
related to changes in intracellular Ba2+. NO did not modify
the duration of feet. Effects were evident even on pre-fusioned
granules, observed under hypertonic conditions, suggesting that the
fusion pore is not the target for NO, which probably acts by modifying
the affinity of catecholamines for the intragranular matrix. NO could
modify the synaptic transmitter efficacy through a novel mechanism,
which involves the regulation of the emptying of secretory vesicles.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
= Imax
Imax/e)
and (
' = Imax/e) taken from the
adjusted exponential decay.

View larger version (15K):
[in a new window]
Fig. 1.
Parameters used for secretory spike kinetics
characterization. For explanation, see "Experimental
Procedures."
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
' increased with 200 nM NO from 12.9 ms
to 20.3, whereas
changed from 27.1 to 42.3 ms, indicating that NO
strongly slowed down the last phase of exocytosis. The observed spike
shape changes were not caused by a decrease in electrode sensitivity,
as SNP did not modify the oxidation curves observed in the flow stream
system used for electrode calibration (data not shown).
The effects of NO on secretory spike parameters
The effects of various NO/guanylate cyclase activators and blockers on
secretory spike parameters (normalized data)

View larger version (25K):
[in a new window]
Fig. 2.
NO effects on spike shape. Histograms
from secretory spikes were obtained in the absence and in the presence
of 10 µM SNP for 10-20 min. Data are from 18 and 23 different cells, respectively. Columns at the
right of each graph indicate an increase in the number of
higher (Imax), wider
(t1/2), larger (Q1/3),
sharper (m), or flatter top (tP)
spikes; Q1/3 results from cubic root of
Q data (see "Experimental Procedures"). Normalized data
are summarized in Table II.
,
', and t1/2. The effect of NO on exocytotic
kinetics occurs in few seconds (Fig. 4).

View larger version (18K):
[in a new window]
Fig. 3.
Representative traces with mean spike
characteristics. Spikes were plotted from the data sets of Table
I. Control spike is indicated by the solid thin
line, spermine-NO by a solid thick
line, and C-PTIO by a dashed
line.

View larger version (18K):
[in a new window]
Fig. 4.
Time course of NO effects on quantal
release. Typical amperometric trace (from five) of a secretory
response from a cell stimulated for 5 s with 5 mM
Ba2+ (dot); 30 s later NO solution was
added to the cell chamber to get an estimated NO concentration of 200 nM (triangle). Vertical
dashed lines indicate periods of 20 s where
t1/2 values were measured. Numbers
between lines show average values for
t1/2. The number of secretory spikes computed
are in parentheses. Calibration bars
are shown on the right.
values were
affected to the same extend,
' increased from 9.47 to 12.7 ms,
whereas
changed from 20.8 to 31.4 ms, indicating that cGMP affected
as well the very last phase of exocytosis.
' from 13.4 to 22.5 ms and
from 30 to 49.3 ms, whereas these values were increased by
IBMX from 19 to 24.7 ms and 36.6 to 47.3 ms, respectively; the addition
of SNP did not significantly modify the
values obtained with
IBMX.
was observed. Fig. 3 summarizes the
effect of 10 min of incubation with a low concentration of C-PTIO (10 nM); spikes became taller and thinner, and the CA concentration reaching electrode was much bigger. Note that NO could
account for 10-fold changes in the CA concentration reaching electrode
(Imax).

View larger version (11K):
[in a new window]
Fig. 5.
The effect of SNP on the time course of
[Ba2+]c. Cells were loaded with fura-2
and recorded as described under "Experimental Procedures." A
pressure-injected pulse of 5 mM BaCl2 was
applied for 5 s as indicated by arrows. Traces show the
time course in the absence (upper trace) and in
the presence of 10 µM SNP (lower
trace). Traces are representative of 10 untreated cells and
6 cells incubated with SNP.
).

View larger version (9K):
[in a new window]
Fig. 6.
Effects of SNP on secretory spikes from
pre-fusioned granules. Cells were incubated in the absence and in
the presence of 10 µM SNP in an hypertonic (750 mosM) Krebs solution. Under these conditions,
Ba2+ stimulation did not evoke secretory spikes until a
brief (5 s) pulse of isotonic saline was applied. The effects of SNP on
pre-fusioned granules are summarized in the table (inset).
Units are the same as in Table I. #, p < 0.01; and *,
p < 0.001 by Mann-Whitney U test.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/water flow into the granule (18,
34), or modifying the affinity of CA for intragranular matrix (35,
19).
/H2O or the
CA/CGA association. However, there are some arguments in favor of the
later: (i) measurements done on feet duration did not support changes
in fusion pore expansion after cell treatment with SNP or 8-Br-cGMP
(Fig. 1
); (ii) NO effects were observed even on pre-fusioned
granules obtained eliciting secretion under hypertonic conditions, and
secretion was elicited only on return to isotonic conditions and (iii)
in these pre-fusioned granules, NO prevented the CA leakage.
Chromogranin A, ATP, and Ca2+ have been implicated in the
intragranular Donnan complexation of CA (15-17). To date, this process
has been considered to be only a passive mechanism for keeping the
intragranular solutes isotonic with the cytoplasm (35). However, it is
known that even little modifications on CGA conformation can account
for large changes on its affinity for CA (19-22, 36).
/water through the granule membrane; however, it is
unlikely that this mechanism could operate under hypertonic conditions.
20 nm),
similar to the width of a synaptic cleft. In the example given in Fig.
3, NO accounts for a 10-fold change in the CA concentration reaching
the electrode or cell surface. The concentration of CA released from a
chromaffin granule, measured by cyclic voltammetry, was estimated to be
around 34 mM (19). Assuming that, during resting
conditions, a variable NO tone was present, NO levels could account for
variations on CA concentration ranging from 8 to 76 mM,
using the same granular content. Hence in sympathetic nerves, NO may
potentiate its own vasodilatory effects by impairing the sympathetic
compensatory activity through a reduction in synaptic efficacy.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
The on-line version of this article (available at
http://www.jbc.org) contains Fig. 1S and legend.
Recipient of a scholarship of Instituto Tecnológico de Canarias.
![]()
ABBREVIATIONS
-nitro-L-arginine methyl ester;
NOS, nitric-oxide synthase;
PKG, cGMP-dependent protein kinase;
SNP, sodium nitroprusside.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Schmidt, H. H. H. W.,
and Walter, U.
(1994)
Cell
78,
919-295
2.
Haley, J. E.,
Wilcox, G. L.,
and Chapman, P. F.
(1992)
Neuron
8,
211-216
3.
Schwartz, P. M.,
Rodríguez-Pascual, F.,
Koesling, D.,
Torres, M.,
and Fostermann, U.
(1998)
Neuroscience
82,
255-265
4.
Torres, M.,
Ceballos, G.,
and Rubio, R.
(1994)
J. Neurochem.
63,
988-996
5.
Marley, P. D.,
McLeod, J.,
Anderson, C.,
and Thomson, K. A.
(1995)
J. Autonom. Nerv. Sys.
54,
184-194
6.
Afework, M.,
Ralevic, V.,
and Burnstock, G.
(1995)
Neurosci. Lett.
190,
109-112
7.
O'Sullivan, A. J.,
and Burgoyne, R. D.
(1990)
J. Neurochem.
54,
1805-1808
8.
Rodríguez-Pascual, F.,
Miras-Portugal, M. T.,
and Torres, M.
(1996)
Mol. Pharmacol.
49,
1058-1070
9.
Oset-Gasque, M. J.,
Parramón, M.,
Hortelano, S.,
Boscá, L.,
and González, M. P.
(1994)
J. Neurochem.
63,
1693-1700
10.
Shono, M.,
Houchi, H.,
Oka, M.,
and Nakaya, Y.
(1997)
J. Cardiovasc. Pharmacol.
30,
419-423
11.
Kumai, T.,
Tanaka, M.,
Tateishi, T.,
Asoh, M.,
and Kobayashi, S.
(1998)
Jpn. J. Pharmacol.
77,
205-210
12.
Moro, M. A.,
Michelena, P.,
Sánchez-García, P.,
Palmer, R.,
Moncada, S.,
and García, A. G.
(1993)
Eur. J. Pharmacol.
246,
213-218
13.
Finnegan, J. M.,
Pihel, K.,
Cahill, P. S.,
Huang, L.,
Zerby, S. E.,
Edwing, A. G.,
Kennedy, R. T.,
and Wightman, R. M.
(1996)
J. Neurochem.
66,
1914-1923
14.
Albillos, A.,
Dernick, G.,
Horstmann, H.,
Almers, W.,
Alvarez de Toledo, G.,
and Lindau, M.
(1997)
Nature
398,
509-512
15.
Kopell, W. N.,
and Westhead, E. W.
(1982)
J. Biol. Chem.
257,
5707-5710
16.
Sen, R.,
and Sharp, R. R.
(1982)
Biochim. Biophys. Acta
721,
70-82
17.
Helle, K. B.,
Reed, R. K.,
Ehrhart, M.,
Aunis, D.,
and Angeletti, R. H.
(1990)
Acta Physiol. Scand.
138,
565-574
18.
Sharp, R. R.,
and Sen, R.
(1982)
Biophys. J.
40,
17-25
19.
Schroeder, T. J.,
Borges, R.,
Finnegan, J. M.,
Pihel, K.,
Amatore, C.,
and Wightman, R. M.
(1996)
Biophys. J.
70,
1061-1068
20.
Leszczyszyn, D. J.,
Jankowski, J. A.,
Viveros, O. H.,
Diliberto, E. J., Jr.,
Near, J. A.,
and Wightman, R. M.
(1990)
J. Biol. Chem.
265,
14736-14737
21.
Pihel, K.,
Travis, E. R.,
Borges, R.,
and Wightman, R. M.
(1996)
Biophys. J.
71,
1633-1640
22.
Borges, R.,
Travis, E. R.,
Hoechstetler, S. E.,
and Wightman, R. M.
(1997)
J. Biol. Chem.
272,
8325-8331
23.
Moro, M. A.,
López, M. G.,
Gandía, L.,
Michelena, P.,
and García, A. G.
(1990)
Anal. Biochem.
185,
243-248
24.
Kawagoe, K. T.,
Zimmerman, J. B.,
and Wightman, R. M.
(1993)
J. Neurosci. Methods
48,
225-240
25.
Ferrero, R.,
Rodríguez-Pascual, F.,
Miras-Portugal, M. T.,
and Torres, M.
(1999)
Br. J. Pharmacol.
127,
779-787
26.
Jankowski, J. A.,
Finnegan, J. M.,
and Wightman, R. M.
(1994)
J. Neurochem.
63,
1739-1747
27.
Alés, E.,
Tabares, L.,
Poyato, J. M.,
Valero, V.,
Lindau, M.,
and Alvarez de Toledo, G.
(1999)
Nat. Cell Biol.
1,
40-44
28.
Hartmann, J.,
and Lindau, M.
(1995)
FEBS Lett.
363,
217-220
29.
Criado, M.,
Gil, S.,
Viniegra, S.,
and Gutiérrez, L. M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7256-7261
30.
Rodríguez-Pascual, F.,
Miras-Portugal, M. T.,
and Torres, M.
(1994)
Neurosci. Lett.
180,
269-272
31.
Nagayama, T.,
Yoshida, M.,
Suzuki-Kusaba, M.,
Hisa, H.,
Kimura, T.,
and Satoh, S.
(1998)
Eur. J. Pharmacol.
353,
169-176
32.
von Ruden, L.,
García, A. G.,
and López, M. G.
(1993)
FEBS Lett.
336,
48-52
33.
Scepek, S.,
Coorssen, J. R.,
and Lindau, M.
(1998)
EMBO J.
17,
4340-4345
34.
Terakawa, S., Tsuboi, T., Kikuta, T., Sakurai, T., Hirano, M., and
Suga, T., (1999) 10th International Symposium on Chromaffin Cell
Biology, Bergen, Norway, August 22-27, Abstract Book S VIII-3, 110
35.
Helle, K. B.
(1990)
Neurochem. Int.
17,
165-175
36.
Rahamimoff, R.,
and Fernández, J. M.
(1997)
Neuron
18,
17-27
37.
Monc, J. R.,
Oberhauser, A. F.,
and Fernández, J. M.
(1995)
Mol. Membr. Biol.
12,
151-156
38.
Yoo, S. H.,
and Albanesi, J. P.
(1991)
J. Biol. Chem.
266,
7740-7745
39.
Yoo, S. H.
(1996)
J. Biol. Chem.
271,
1558-1565
40.
Komalavilas, P.,
and Lincoln, T. M.
(1994)
J. Biol. Chem.
269,
8701-8707
41.
Teraoka, H.,
Takai, R.,
Taneike, T.,
Hiraga, T.,
and Ohga, A.
(1996)
Jpn. J. Pharmacol.
72,
307-315
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Camacho, J. D. Machado, J. Alvarez, and R. Borges Intravesicular Calcium Release Mediates the Motion and Exocytosis of Secretory Organelles: A STUDY WITH ADRENAL CHROMAFFIN CELLS J. Biol. Chem., August 15, 2008; 283(33): 22383 - 22389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Montesinos, J. D. Machado, M. Camacho, J. Diaz, Y. G. Morales, D. Alvarez de la Rosa, E. Carmona, A. Castaneyra, O. H. Viveros, D. T. O'Connor, et al. The Crucial Role of Chromogranins in Storage and Exocytosis Revealed Using Chromaffin Cells from Chromogranin A Null Mouse J. Neurosci., March 26, 2008; 28(13): 3350 - 3358. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Saad, C. Shimamoto, T. Nakahari, S. Fujiwara, K.-i. Katsu, and Y. Marunaka cGMP modulation of ACh-stimulated exocytosis in guinea pig antral mucous cells Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1138 - G1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, K. S. Tang, V. B. Lu, C. P. Weerasinghe, A. Tse, and F. W. Tse Maintenance of quantal size and immediately releasable granules in rat chromaffin cells by glucocorticoid Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1122 - C1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Mahapatra, M. Mahata, P. P. Hazra, P. M. McDonough, D. T. O'Connor, and S. K. Mahata A Dynamic Pool of Calcium in Catecholamine Storage Vesicles: EXPLORATION IN LIVING CELLS BY A NOVEL VESICLE-TARGETED CHROMOGRANIN A-AEQUORIN CHIMERIC PHOTOPROTEIN J. Biol. Chem., December 3, 2004; 279(49): 51107 - 51121. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Axmacher, M. Stemmler, D. Engel, A. Draguhn, and R. Ritz Transmitter Metabolism as a Mechanism of Synaptic Plasticity: A Modeling Study J Neurophysiol, January 1, 2004; 91(1): 25 - 39. [Abstract] [Full Text] |
||||
![]() |
S. A. Andric, A. E. Gonzalez-Iglesias, F. Van Goor, M. Tomic, and S. S. Stojilkovic Nitric Oxide Inhibits Prolactin Secretion in Pituitary Cells Downstream of Voltage-Gated Calcium Influx Endocrinology, July 1, 2003; 144(7): 2912 - 2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Burgoyne and A. Morgan Secretory Granule Exocytosis Physiol Rev, April 1, 2003; 83(2): 581 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Machado, J. F. Gomez, G. Betancor, M. Camacho, M. A. Brioso, and R. Borges Hydralazine Reduces the Quantal Size of Secretory Events by Displacement of Catecholamines From Adrenomedullary Chromaffin Secretory Vesicles Circ. Res., November 1, 2002; 91(9): 830 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Graham, D. W. O'Callaghan, H. T. McMahon, and R. D. Burgoyne Dynamin-dependent and dynamin-independent processes contribute to the regulation of single vesicle release kinetics and quantal size PNAS, May 14, 2002; 99(10): 7124 - 7129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Machado, C. Alonso, A. Morales, J. F. Gomez, and R. Borges Nongenomic Regulation of the Kinetics of Exocytosis by Estrogens J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takekoshi, K. Ishii, S. Shibuya, Y. Kawakami, K. Isobe, and T. Nakai Angiotensin II Type 2 Receptor Counter-Regulates Type 1 Receptor in Catecholamine Synthesis in Cultured Porcine Adrenal Medullary Chromaffin Cells Hypertension, January 1, 2002; 39(1): 142 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Machado, A. Morales, J. F. Gomez, and R. Borges cAMP Modulates Exocytotic Kinetics and Increases Quantal Size in Chromaffin Cells Mol. Pharmacol., September 1, 2001; 60(3): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||